Risk of Oxygen During Cardiac Surgery Trial
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 213 participants.
Also called NCT02361944
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 213 participants
- Sponsor
- Registry
-
NCT02361944
-
- Other papers using this trial's data
- Effects of Oxygen on Perioperative Vascular Function: A Randomized Clinical Trial
- Intraoperative Oxygen Treatment, Oxidative Stress, and Organ Injury Following Cardiac Surgery: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02361944. Randomized; double masking; primary purpose prevention. Start 2016-04-05 (actual); primary completion 2020-10-08 (actual). Results posted on 2023-08-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Risk of Oxygen During Cardiac Surgery Trial
- Acronym
- ROCS
- Condition
- Cardiac Surgery
- Intervention (Drug)
- Oxygen - normoxia
- Intervention (Drug)
- Oxygen - hyperoxia
- Lead sponsor
- Vanderbilt University
- Collaborator
- National Institute of General Medical Sciences (NIGMS)
Record details
- Record id
cardio:ct-nct02361944- Content hash
8721e4ceddccd3c20dd8a55302187e05f012dec98f50c3b21cd2d20fdb98771c